Ocular KRIYA-825 ameliorates retinal degeneration in mice, study shows May 14, 2024 A new adeno-associated viral vector-driven CR2-CR1 fusion protein, named KRIYA-825, was tested in vivo in mice with sodium iodate-induced geographic atrophy.Read More
Ocular Kriya Therapeutics aims to advance up to five programs into clinic by end of 2025 Jan. 9, 2024 Kriya Therapeutics Inc. has offered an update on its pipeline of gene therapies for indications in ophthalmology, metabolic disease and neurology.Read More
